Applied Health Economics and Health Policy

Article	Citations
Cost-Effectiveness of Perinatal Depression Screening: A Scoping Review	139
Cost-Effectiveness and Value of Information Analyses of Caplacizumab for the Treatment of Thrombotic Thrombocytopenic Purpura in Brazil	72
Assessing the Direct Impact of Death on Discrete Choice Experiment Utilities	40
Approaches to Incorporation of Preferences into Health Economic Models of Genomic Medicine: A Critical Interpretive Synthesis and Conceptual Framework	38
Therapy, Pills and Unmet Needs for Financial Reasons: Socioeconomic Inequalities and Inequities in Access to Mental Health Care in Spain 2014–2020	33
Cost-Effectiveness of a Universal School-Based Mental Health Prevention Program: An Economic Modeling Study in a Limited Income Context	32
Cost-Effectiveness Analysis of Evolocumab or Inclisiran in Combination with Statins Versus Statin Monotherapy Among Patients with ASCVD in China	30
Which Factors are Holding up the Integration of the Environmental Impact of Health Technologies in Health Technology Assessment? Insights from a Multi-Stakeholder Interview Study	27
Cost-Effective and Sustainable Drug Use in Hospitals: A Systematic and Practice-Based Approach	27
Deterministic and Probabilistic Analysis of a Simple Markov Model: How Different Could They Be?	23
Population Norms for SF-6Dv2 and EQ-5D-5L in China	23
Applications of Behavioral Economics to Pharmaceutical Policymaking: A Scoping Review with Implications for Best-Value Biological Medicines	22
Economic Evaluation of Evusheld for Preexposure Prevention of COVID-19 in High-Risk Populations: Early Evidence from Thailand	22
The Economics of Antibiotic Resistance: A Systematic Review and Meta-analysis Based on Global Research	21
Exploratory Approach to Incorporating Carbon Footprint in Health Technology Assessment (HTA) Modelling: Cost-Effectiveness Analysis of Health Interventions in the United Kingdom	21
The Effect of Price Changes and Teaspoon Labelling on Intention to Purchase Sugar-Sweetened Beverages: A Discrete Choice Experiment	21
A Guideline-Implementation Intervention to Improve the Management of Low Back Pain in Primary Care: A Difference-in-Difference-in-Differences Analysis	20
Psychometric Evaluation of the PedsQL GCS and CHU9D in Australian Children and Adolescents with Common Chronic Health Conditions	19
Selection and Prioritization of Medical Devices for HTA Evaluation: A Systematic Review of Existing Approaches	19
Local Level Economic Evaluation: What is it? What is its Value? Is it Sustainable?	19
The Economic Cost of Rising Non-communicable Diseases in India: A Systematic Literature Review of Methods and Estimates	18
Correction to: Cost Effectiveness of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Patients with Knee Osteoarthritis	17
A Systematic Review of the World’s Largest Government Sponsored Health Insurance Scheme for 500 Million Beneficiaries in India: Pradhan Mantri Jan Arogya Yojana	16
10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?	16
Financing Comprehensive Immunization Services in Lao PDR: A Fiscal Space Analysis From a Public Policy Perspective	15

How is Value Defined in Molecular Testing in Cancer? A Scoping Review	14
Including Pharmaceuticals in Bundled Payments	14
Economic Evaluation Evidence for Resource-Allocation Decision Making: Bridging the Gap for Local Decision Makers Using English Case Studies	14
Correction: Deterministic and Probabilistic Analysis of a Simple Markov Model: How Different Could They Be?	14
Scope Issue in Contingent Valuation Studies of the COVID-19 Vaccine: The Case of China	13
Social Costs of Smoking in the Czech Republic	12
Estimating the Health Effects of Expansions in Health Expenditure in Indonesia: A Dynamic Panel Data Approach	12
Economic Effects of Fixed-Dose Versus Loose-Dose Combination Therapy for Type 2 Diabetes Patients	12
How Much Should be Invested in Lung Care Across the WHO European Region? Applying a Monetary Value to Disability-Adjusted Life-Years Within the International Respiratory Coalition’s Lung Facts	12
Valuation of Costs in Health Economics During Financial and Economic Crises: A Case Study from Lebanon	11
Contextual Factors that Influence Antibiotic Prescribing: A Discrete Choice Experiment of GP Registrars	11
The Impact of Unrelated Future Medical Costs on Economic Evaluation Outcomes for Different Models of Diabetes	11
Development of a Health Technology Assessment Quality Appraisal Checklist (HTA-QAC) for India	10
Is Economic Evaluation and Care Commissioning Focused on Achieving the Same Outcomes? Resource-Allocation Considerations and Challenges Using England as a Case Study	10
Correction to: Different Frameworks, Similar Results? Head-to-Head Comparison of the Generic Preference-Based Health-Outcome Measures CS-Base and EQ-5D-5L	10
A Systematic Review of Cost-Effectiveness Analyses of Colorectal Cancer Screening in Europe: Have Studies Included Optimal Screening Intensities?	10
Measures of Performance and Clinical Superiority Thresholds for ‘Test-and-treat’ Predictive Biomarkers	10
Guiding Health Resource Allocation: Using Population Net Health Benefit to Align Disease Burden with Cost Effectiveness for Informed Decision Making	10
Cost-Effectiveness of Anti-retroviral Adherence Interventions for People Living with HIV: A Systematic Review of Decision Analytical Models	9
Herd Immunity Effects in Cost-Effectiveness Analyses among Low- and Middle-Income Countries	9
Cost-Effectiveness and Budget Impact Analysis of Implementing a 'Soft Opt-Out' System for Kidney Donation in Australia	9
Trump’s Drug Pricing Order and the Domestic Economic Trade-Off	9
Does the Choice of Health Metric, DALY or QALY, Influence Conclusions of Health Economic Evaluation? A Case Study of Rotavirus Vaccine in Burundi	9
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations	9
Machine Learning-Assisted Health Economics and Policy Reviews: A Comparative Assessment	9
Projected Impact on Labour Productivity Costs of Cancer-Related Premature Mortality in Europe 2018–2040	9
Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy	9
Value and Price of Multi-indication Cancer Drugs in the USA, Germany, France, England, Canada, Australia, and Scotland	8
Use of Cost-Effectiveness Thresholds in Healthcare Public Policy: Progress and Challenges	8
Productivity Loss and Indirect Costs for Patients Newly Diagnosed with Early- versus Late-Stage Cancer in the USA: A Large-Scale Observational Research Study	8
Mechanisms Considering Public Investment in Pricing and Reimbursement Decisions of Medicines and Other Health Technologies: A Scoping Review	8
Effect of Competition on Generic Drug Prices	8
Sedaconda ACD-S for Sedation with Volatile Anaesthetics in Intensive Care: A NICE Medical Technologies Guidance	8
Young People’s Preferences for Web-Based Mental Health Interventions for Managing Anxiety and Depression: A Discrete Choice Experiment	8
Comparing Preferences for Disease Profiles: A Discrete Choice Experiment from a US Societal Perspective	8
Measurement of Catastrophic Health Expenditure in India: A Systematic Review and Meta-Analysis	8
The Health Economics of Genomic Technologies: A Growing Evidence Base on Value	7
The Effects of School Closures on COVID-19: A Cross-Country Panel Analysis	7
Willingness to Pay for National Health Insurance: A Contingent Valuation Study Among Patients Visiting Public Hospitals in Melaka, Malaysia	7
Cost-effectiveness Analysis of the Dental RECUR Pragmatic Randomized Controlled Trial: Evaluating a Goal-oriented Talking Intervention to Prevent Reoccurrence of Dental Caries in Children	7
Societal Cost of Racial Pneumococcal Disease Disparities in US Adults Aged 50 Years or Older	7
The Broader Opportunity Costs in the Broader Cost-Effectiveness Analysis Framework	7
Information Asymmetry in Hospitals: Evidence of the Lack of Cost Awareness in Clinicians	7
Forecasting the Incremental Value to Society Created by a Class of New Prescription Drugs: A Proposed Methodology and Its Application to Treating Chronic Hepatitis C in India	7
The Limitations and Potentials of Evaluating Economic Aspects of Community-Based Health Promotion: A Critical Review	7
Analysing the Efficiency of Health Systems: A Systematic Review of the Literature	7
Cost-Effectiveness of Once-Weekly Semaglutide 1 mg versus Canagliflozin 300 mg in Patients with Type 2 Diabetes Mellitus in a Canadian Setting	7
Estimating a Drug’s Price After Loss of Exclusivity as a Function of Its Cost of Goods Sold	7
A Systematic Review of Economic Evaluations on Interventions Targeting Insomnia or Hypersomnia	7
EQ-5D-5L Population Norms for Italy	6

The Impact of Value-Based Payment Models for Networks of Care and Transmural Care: A Systematic Literature Review	6
Discrete Event Simulation in R using the ‘Simmer’ Package for Health Economic Modelling: A Tutorial and Illustration in Colon Cancer	6
A Head-On Comparison of EQ-VT- and Crosswalk-Based EQ-5D-5L Value Sets	6
Exploring Consumer Preferences for Cannabis Vaping Products to Support Public Health Policy: A Discrete Choice Experiment	6
Using Genomic Heterogeneity to Inform Therapeutic Decisions for Metastatic Colorectal Cancer: An Application of the Value of Heterogeneity Framework	6
Headroom Analysis for Early Economic Evaluation: A Systematic Review	6
Model-Based Economic Evaluations of Interventions for Dementia: An Updated Systematic Review and Quality Assessment	6
Discrete Choice Experiments in Health State Valuation: A Systematic Review of Progress and New Trends	5
Use of Decision-Analytic Modelling to Assess the Cost-Effectiveness of Diagnostic Imaging of the Spine, Shoulder, and Knee: A Scoping Review	5
Should Hungary Pay More for a QALY Gain than Higher-Income Western European Countries?	5
How Did the Affordable Care Act Affect Risky Health Behaviors?	5
Utilising Health Technology Assessment to Develop Managed Access Protocols to Facilitate Drug Reimbursement in Ireland	5
Structured Expert Elicitation to Inform Long-Term Survival Extrapolations in Advanced Renal Cell Carcinoma	5
A Systematic Review of Health Economic Evaluations and Budget Impact Analyses to Inform Healthcare Decision-Making in Central America	5
Health Reform in Aotearoa New Zealand: Insights on Health Equity Challenges One Year On	5
Are Estimates of the Health Opportunity Cost Being Used to Draw Conclusions in Published Cost-Effectiveness Analyses? A Scoping Review in Four Countries	5
New Horizons? Assessing General Public Preferences for a Wellbeing Economy in the Post-COVID-19 World	5
Estimated Carbon Savings from Changing Surgical Trends in Primary Elective Total Hip Arthroplasty in England: A Retrospective Observational Study	5
Acknowledgement to Referees	5
Modelled Distributional Cost-Effectiveness Analysis of Childhood Obesity Interventions: A Demonstration	5
Genetic Test Utilization and Cost among Families of Children Evaluated for Genetic Conditions: An Analysis of USA Commercial Claims Data	5
The Role of Price Variation in Economic Analyses for Cancer Screenings: A Rapid Review	5
Correction to: Cost-Effectiveness of Once-Weekly Semaglutide 1 mg versus Canaglifozin 300 mg in Patients with Type 2 Diabetes Mellitus in a Canadian Setting	4
Using Economics to Impact Local Obesity Policy: Introducing the UK Centre for Economics of Obesity (CEO)	4
Cost-Utility Analysis of TNF-α Inhibitors, B Cell Inhibitors, and JAK Inhibitors Versus csDMARDs for Rheumatoid Arthritis Treatment	4
The Value of New: Consideration of Product Novelty in Health Technology Assessments of Pharmaceuticals	4
Cost Effectiveness of Molecular Diagnostic Testing Algorithms for the Treatment Selection of Frontline Ibrutinib for Patients with Chronic Lymphocytic Leukemia in Australia	4
Economic Evaluation of Oral Nucleos(t)ide Analogues for Patients with Chronic Hepatitis B in Thailand	4
Economic Evaluations of Preventive Interventions for Dental Caries and Periodontitis: A Systematic Review	4
Productivity Losses due to Health Problems Arising from COVID-19 Pandemic: A Systematic Review of Population-Level Studies Worldwide	4
The Impact of Alteplase Coverage on Health Equity for the Treatment of Ischemic Stroke in the USA: A Distributional Cost-Effectiveness Analysis	4
A Model-Based Estimate of the Cost-Effectiveness Threshold in Germany	4
Economic Epidemiology: A Framework to Study Interactions of Epidemics and the Economy	4
Cost Effectiveness of Deep Brain Stimulation for Parkinson’s Disease: A Systematic Review	4
Review and Assessment of Policy Options for Improving Access to Combination Therapies in Oncology in Europe	4
Correction: Economic Evaluations of Robotic-Assisted Surgery: Methods, Challenges and Opportunities	4
Cost-Effectiveness and Value of Information Analysis of an Ambient Intelligent Geriatric Management (AmbIGeM) System Compared to Usual Care to Prevent Falls in Older People in Hospitals	4
Quality-Adjusted Life Expectancy Norms Based on the EQ-5D-5L and SF-6Dv2 for China	4
Willingness to Pay per QALY: A Systematic Review of Demand-Side Valuations with a Focus on Age and Disease Severity	4
Preferred Attributes of Care Pathways for Obstructive Sleep Apnoea from the Perspective of Diagnosed Patients and High-Risk Individuals: A Discrete Choice Experiment	4
Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options	3
A Case Study on Reviewing Specialist Services Commissioning in Wales: TAVI for Severe Aortic Stenosis	3
The Cost-Effectiveness of Adjunctive Lifestyle Interventions for the Management of Cancer: A Systematic Review	3
Beyond the Diagnosis: Valuing Genome-Wide Sequencing for Rare Disease Diagnosis Using Contingent Valuation	3
Estimating Transition Probabilities for Modeling Major Depression in Adolescents by Sex and Race or Ethnicity Combinations in the USA	3
Value is Gendered: The Need for Sex and Gender Considerations in Health Economic Evaluations	3
Predicting Health Utilities Using Health Administrative Data: Leveraging Survey-linked Health Administrative Data from Ontario, Canada	3
Cost Effectiveness of Pharmacological Management for Osteoarthritis: A Systematic Review	3
Opportunities for CMS to Further Specify and Broaden Its Approach to Assessing Unmet Medical Need in the Context of the Medicare Drug Price Negotiation Program	3
Population-Based Testing for Undiagnosed Hepatitis C: A Systematic Review of Economic Evaluations	3
Informing Structural Assumptions for Three State Oncology Cost-Effectiveness Models through Model Efficiency and Fit	3
How Does the New Australian EQ-5D-5L Value Set Impact Utility Scores? Analysis of Data from the Australian Orthopaedic Association National Joint Replacement Registry	3
Modelling Informal Carers’ Health-Related Quality of Life: Challenges for Economic Evaluation	3
Acknowledgement to Referees	3
Alternative Payment Models for Innovative Medicines: A Framework for Effective Implementation	3
The Short Form 6 Dimensions (SF-6D): Development and Evolution	3
Evolving Evidence-Based Value Assessment of One-Time Therapies: Tisagenlecleucel as a Case Study	3
Comparison of the Measurement Properties of EQ-5D-5L and SF-6Dv2 in COVID-19 Patients in China	3
myCOPD App for Managing Chronic Obstructive Pulmonary Disease: A NICE Medical Technology Guidance for a Digital Health Technology	3
Cost Effectiveness of Adding Fenfluramine to Standard of Care for Patients with Dravet Syndrome in Sweden	3
The Assessment of Patient-Reported Outcomes for the Authorisation of Medicines in Europe: A Review of European Public Assessment Reports from 2017 to 2022	3
The Cost Effectiveness of Elective Surgical Procedures with Longer NHS Waiting Lists: A Targeted Review	3
Evaluating the Short-Term Costs and Benefits of a Nationwide Diabetes Prevention Programme in England: Retrospective Observational Study	3
The Impact of the Approach to Accounting for Age and Sex in Economic Models on Predicted Quality-Adjusted Life-Years	2
Financial Incentives in the Path to Recovery from the COVID-19 Pandemic	2
The Hidden Toll of Psychological Distress in Australian Adults and Its Impact on Health-Related Quality of Life Measured as Health State Utilities	2
Real-World Health and Economic Effects of a Large-Scale Outpatient Screening and Continuing Care Programme for Early Detection and Care of Microvascular Complications in Patients with Type 2 Diabetes	2
Challenges in the Evaluation of Emerging Highly Specialised Technologies: Is There a Role for Living HTA?	2
An Investigation into the Relationship Between Choice of Model Structure and How to Adjust for Subsequent Therapies Using a Case Study in Oncology	2
Economic Evaluation of a Tumour-Agnostic Therapy: Dutch Economic Value of Larotrectinib in TRK Fusion-Positive Cancers	2
Rationing in an Era of Multiple Tight Constraints: Is Cost-Utility Analysis Still Fit for Purpose?	2
Healthcare Costs and Carbon Emissions of Stage III Melanoma Surveillance Imaging	2
The Cost Effectiveness of Genomic Medicine in Cancer Control: A Systematic Literature Review	2
Measurement of Health-Related Quality of Life from Conception to Postpartum Using the EQ-5D-5L Among a National Sample of US Pregnant and Postpartum Adults	2
What Interventions are Cost Effective in Reducing Violence Against Women? A Scoping Review	2
Different Frameworks, Similar Results? Head-to-Head Comparison of the Generic Preference-Based Health-Outcome Measures CS-Base and EQ-5D-5L	2
Antimicrobial Resistance (AMR) Development Map: A Conceptual Map and a Tool to Support Economic Evaluation of AMR Interventions	2
Health Interventions May Have Divergent Impacts on Health and Economic Equity: A Case Study of the Community-Based Hypertension Improvement Project in Ghana	2
Adding a Gene Expression Profile Test to Aid Differential Diagnosis and Treatment in Aggressive Large B-Cell Lymphoma: An Early Exploratory Economic Evaluation	2
A Contingent Valuation Study for Use in Valuing Public Goods with Health Externalities: The Case of Street Pianos	2

Budget Impact Analysis of the FreeStyle Libre Flash Continuous Glucose Monitoring System® in Patients with Type 1 Diabetes Mellitus and Type 2 Diabetes Mellitus with Multiple Daily Insulin Injections	2
The Economic Impact of Community Paramedics Within Emergency Medical Services: A Systematic Review	2
The Cost-Effectiveness of Initiating Patients on Home Dialysis Compared with In-Centre Haemodialysis	2
Economic Evaluation of COVID-19 Immunization Strategies: A Systematic Review and Narrative Synthesis	2
UroLift for Treating Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A NICE Medical Technology Guidance Update	2
Treatment Preferences of Adolescents and Young Adults with Depressive Symptoms: A Discrete Choice Experiment	2
Is the Use of Unanchored Matching-Adjusted Indirect Comparison Always Superior to Naïve Indirect Comparison on Survival Outcomes? A Simulation Study	2
The Inflation Reduction Act: Hope for Prescription Drug Prices in the USA	2
Are Drug Novelty Characteristics Associated With Greater Health Benefits?	2
A Systematic Review of Kidney Transplantation Decision Modelling Studies	2
A Multi-dimensional Framework of Valued Output for Primary Care in England	2
Episcissors-60 for Mediolateral Episiotomy: Evaluation of Clinical and Economic Evidence to Inform NICE Medical Technologies Guidance	2
The Gift of Time, How Do I Want to Spend It? Exploring Preferences for Time Allocation Among Women with and without a Breast Cancer Diagnosis	2
Is There Broad-Based Support in High-Income Countries for COVID-19 Vaccine Donation? Evidence from Seven Countries	2
Australian Preferences for Prenatal Screening: A Discrete Choice Experiment Comparing Metropolitan and Rural/Regional Areas	2
Cost-Utility Analysis of Major System Change in Specialist Cancer Surgery in London, England, Using Linked Patient-Level Electronic Health Records and Difference-in-Differences Analysis	2
Cost Effectiveness of Ribociclib and Palbociclib in the Second-Line Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer in Post-Menopausal Indian Women	2
Comment on: “10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?”	2
Cost of Carbon in the Total Cost of a Healthcare Procedure: Example of Micro-Costing Study in a French Setting	2
Methods and Practical Considerations for Conducting Budget Impact Analysis for Non-Pharmaceutical Interventions	2
Cost-Effectiveness Analysis of Stockholm 3 Testing Compared to PSA as the Primary Blood Test in the Prostate Cancer Diagnostic Pathway: A Decision Tree Approach	2
Compulsory Licensing as an Instrument to Tackle High Medicine Prices: A Realist Review of Industrial and Health Consequences	2
Willingness to Pay for One Additional Quality Adjusted Life Year: A Population Based Survey from China	2
Correction: Exploring the Integration of Environmental Impacts in the Cost Analysis of the Pilot MEL-SELF Trial of Patient-Led Melanoma Surveillance	2
The False Economy of Seeking to Eliminate Delayed Transfers of Care: Some Lessons from Queueing Theory	2